NM_012293.3:c.3593G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_012293.3(PXDN):​c.3593G>A​(p.Arg1198Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0024 in 1,611,760 control chromosomes in the GnomAD database, including 82 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1198W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.012 ( 39 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 43 hom. )

Consequence

PXDN
NM_012293.3 missense

Scores

5
5
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 7.80

Publications

1 publications found
Variant links:
Genes affected
PXDN (HGNC:14966): (peroxidasin) This gene encodes a heme-containing peroxidase that is secreted into the extracellular matrix. It is involved in extracellular matrix formation, and may function in the physiological and pathological fibrogenic response in fibrotic kidney. Mutations in this gene cause corneal opacification and other ocular anomalies, and also microphthalmia and anterior segment dysgenesis. [provided by RefSeq, Aug 2014]
PXDN Gene-Disease associations (from GenCC):
  • anterior segment dysgenesis 7
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, PanelApp Australia, ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007972747).
BP6
Variant 2-1648187-C-T is Benign according to our data. Variant chr2-1648187-C-T is described in CliVar as Benign. Clinvar id is 471915.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-1648187-C-T is described in CliVar as Benign. Clinvar id is 471915.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-1648187-C-T is described in CliVar as Benign. Clinvar id is 471915.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0124 (1891/152236) while in subpopulation AFR AF = 0.043 (1786/41538). AF 95% confidence interval is 0.0413. There are 39 homozygotes in GnomAd4. There are 886 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 39 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PXDNNM_012293.3 linkc.3593G>A p.Arg1198Gln missense_variant Exon 17 of 23 ENST00000252804.9 NP_036425.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PXDNENST00000252804.9 linkc.3593G>A p.Arg1198Gln missense_variant Exon 17 of 23 1 NM_012293.3 ENSP00000252804.4 Q92626-1
PXDNENST00000478155.5 linkn.2697-3435G>A intron_variant Intron 9 of 14 2

Frequencies

GnomAD3 genomes
AF:
0.0124
AC:
1886
AN:
152118
Hom.:
39
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0430
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00485
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00955
GnomAD2 exomes
AF:
0.00331
AC:
816
AN:
246852
AF XY:
0.00251
show subpopulations
Gnomad AFR exome
AF:
0.0467
Gnomad AMR exome
AF:
0.00194
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000992
Gnomad OTH exome
AF:
0.00215
GnomAD4 exome
AF:
0.00136
AC:
1980
AN:
1459524
Hom.:
43
Cov.:
31
AF XY:
0.00114
AC XY:
824
AN XY:
725584
show subpopulations
African (AFR)
AF:
0.0475
AC:
1588
AN:
33438
American (AMR)
AF:
0.00233
AC:
104
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26102
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39644
South Asian (SAS)
AF:
0.000197
AC:
17
AN:
86204
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53360
Middle Eastern (MID)
AF:
0.00538
AC:
31
AN:
5758
European-Non Finnish (NFE)
AF:
0.0000604
AC:
67
AN:
1110040
Other (OTH)
AF:
0.00285
AC:
172
AN:
60310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
119
237
356
474
593
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0124
AC:
1891
AN:
152236
Hom.:
39
Cov.:
33
AF XY:
0.0119
AC XY:
886
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.0430
AC:
1786
AN:
41538
American (AMR)
AF:
0.00484
AC:
74
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68022
Other (OTH)
AF:
0.00945
AC:
20
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
86
171
257
342
428
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00433
Hom.:
46
Bravo
AF:
0.0143
ESP6500AA
AF:
0.0426
AC:
170
ESP6500EA
AF:
0.000120
AC:
1
ExAC
AF:
0.00370
AC:
447
EpiCase
AF:
0.000164
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 13, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Anterior segment dysgenesis 7 Benign:1
Dec 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.13
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.22
T
Eigen
Pathogenic
0.84
Eigen_PC
Pathogenic
0.82
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
D
MetaRNN
Benign
0.0080
T
MetaSVM
Benign
-0.44
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
7.8
PrimateAI
Benign
0.43
T
PROVEAN
Uncertain
-3.7
D
REVEL
Uncertain
0.47
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.018
D
Polyphen
1.0
D
Vest4
0.84
MVP
0.78
MPC
1.3
ClinPred
0.023
T
GERP RS
5.5
Varity_R
0.86
gMVP
0.85
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6723697; hg19: chr2-1651959; API